Evidence map›Paper›PMID 27366167›Full record

ArticleThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale2016

Comparative Evaluation of the BD Phoenix Yeast ID Panel and Remel RapID Yeast Plus System for Yeast Identification.

Michelle L Grant, Shobha Parajuli, Raquel Deleon-Gonsalves, Raghava Potula, Allan L Truant

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Brazilian guidelines for the diagnosis and treatment of candidemia and invasive candidiasis in adults and children.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Guideline
  2. Overview of Risk Factors and Diagnosis of Invasive Candidiasis.Journal of fungi (Basel, Switzerland) · 2026
    Review
  3. Article
  4. An Update onFrontiers in microbiology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michelle L GrantDepartments of Pathology and Laboratory Medicine, Temple University Hospital and School of Medicine, Philadelphia, PA 19140, USA.
Shobha ParajuliDepartments of Pathology and Laboratory Medicine, Temple University Hospital and School of Medicine, Philadelphia, PA 19140, USA.
Raquel Deleon-GonsalvesClinical Microbiology, Immunology and Virology Laboratories, Temple University Hospital and School of Medicine, Philadelphia, PA 19140, USA.
Raghava PotulaDepartments of Pathology and Laboratory Medicine, Temple University Hospital and School of Medicine, Philadelphia, PA 19140, USA; Clinical Microbiology, Immunology and Virology Laboratories, Temple University Hospital and School of Medicine, Philadelphia, PA 19140, USA.
Allan L TruantDepartments of Pathology and Laboratory Medicine, Temple University Hospital and School of Medicine, Philadelphia, PA 19140, USA; Clinical Microbiology, Immunology and Virology Laboratories, Temple University Hospital and School of Medicine, Philadelphia, PA 19140, USA; Microbiology and Immunology, Temple University Hospital and School of Medicine, Philadelphia, PA 19140, USA; Internal Medicine, Temple University Hospital and School of Medicine, Philadelphia, PA 19140, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Becton Dickinson Phoenix Yeast ID Panel was compared to the Remel RapID Yeast Plus System using 150 recent clinical yeast isolates and the API 20C AUX system to resolve discrepant results. The concordance rate between the Yeast ID Panel and the RapID Yeast Plus System (without arbitration) was 93.3% with 97.3% (146/150) and 95.3% (143/150) of the isolates correctly identified by the Becton Dickinson Phoenix and the Remel RapID, respectively, with arbitration.

Identifiers

PMID27366167
PMCPMC4904582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.